Cognizant is buying privately held health-care IT company Trizetto for $2.7 billion in cash, the company announced on Monday.» Read More
Federal health experts say Novo Nordisk's diabetes drug Victoza should be approved for a new use in treating obesity.
JPMorgan's CEO Jamie Dimon finished his radiation and chemotherapy treatment this week, The Wall Street Journal reported.
U.S. regulators are greenlighting a new weight-loss drug called Contrave, the third in a string of approvals for anti-obesity treatments.
The Bill & Melinda Gates Foundation pledged $50 million to support emergency efforts to contain West Africa's Ebola epidemic.
Health insurance premiums for the nearly 150 million people who get family coverage through employers rose a modest 3 percent in 2014.
While calling for the decriminalization of drugs, Sir Richard Branson tells CNBC he does not see the Virgin Group getting into the business of legalized pot.
William Ackman criticized Allergan's board of directors, urging them to "wake up" and at least listen to potential purchaser Valeant Pharmaceuticals.
Ilan Ganot left his banking job to form a company to develop drugs to treat his 4-year-old son, who has Duchenne muscular dystrophy.
Obamacare's cost for small businesses are anything but small, with $22.6 billion in reduced pay and 350,000 fewer jobs, a new analysis finds.
Obamacare ranks very low when the most enthusiastic voters are asked he main reason they're excited about voting in upcoming Congressional elections.
A new pilot study suggests that signs of autism symptoms can be erased if babies begin therapy even before they can toddle.
Gilead is already among the 10 best performers in the Nasdaq 100 this year. So can anything slow this behemoth down? If you ask the analysts, it sounds unlikely.
Virginia Gov. Terry McAuliffe, stymied in his efforts to expand Medicaid in the state, Monday said he would extend health coverage to 25,000 people.
Joan Rivers was inarguably unique in life—with her lacerating, celebrity-seeking missile of a wit. But here's what makes her unique in court.
There is a worrying lack of new billion-dollar "blockbuster" medicines in the pharma sector.
AbbVie and Teva were sued by the FTC for allegedly illegally preventing generic production of AndroGel, used by men with low testosterone.
About 310,000 people could lose HealthCare.gov plans by Sept. 30 if they don't verify they are citizens or legal residents by Friday.
Premiums for benchmark Obamacare plans will drop an average of 0.8 percent in 16 cities, a new study found.
The HealthCare.gov insurance site was breached by a hacker in July, but personal data appears to have remained safe.
U.S. regulators granted accelerated approval to Merck's Keytruda drug, a new type of melanoma treatment for patients with advanced melanoma.
Get the best of CNBC in your inbox